Ocular Therapeutix, Inc. (OCUL)
USD 8.8
(3.17%)
USD 8.8
(3.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 83.38 Million USD | 29.72% |
| 2022 | 64.28 Million USD | 8.99% |
| 2021 | 58.98 Million USD | 0.93% |
| 2020 | 58.43 Million USD | -1.52% |
| 2019 | 59.34 Million USD | 139.4% |
| 2018 | 24.78 Million USD | 37.59% |
| 2017 | 18.01 Million USD | 15.17% |
| 2016 | 15.64 Million USD | 2.43% |
| 2015 | 15.27 Million USD | 2.74% |
| 2014 | 14.86 Million USD | 505.01% |
| 2013 | 2.45 Million USD | -39.56% |
| 2012 | 4.06 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 74.88 Million USD | 0.65% |
| 2024 Q1 | 74.4 Million USD | -10.77% |
| 2023 Q3 | 83.01 Million USD | 28.18% |
| 2023 Q1 | 64.61 Million USD | 0.51% |
| 2023 FY | 83.38 Million USD | 29.72% |
| 2023 Q2 | 64.76 Million USD | 0.24% |
| 2023 Q4 | 83.38 Million USD | 0.45% |
| 2022 Q2 | 59.46 Million USD | 0.4% |
| 2022 Q3 | 59.69 Million USD | 0.39% |
| 2022 FY | 64.28 Million USD | 8.99% |
| 2022 Q4 | 64.28 Million USD | 7.68% |
| 2022 Q1 | 59.22 Million USD | 0.41% |
| 2021 Q2 | 58.49 Million USD | 3.33% |
| 2021 Q1 | 56.6 Million USD | -3.13% |
| 2021 Q3 | 58.73 Million USD | 0.4% |
| 2021 FY | 58.98 Million USD | 0.93% |
| 2021 Q4 | 58.98 Million USD | 0.43% |
| 2020 Q1 | 60.13 Million USD | 1.33% |
| 2020 FY | 58.43 Million USD | -1.52% |
| 2020 Q4 | 58.43 Million USD | 0.45% |
| 2020 Q3 | 58.17 Million USD | -4.57% |
| 2020 Q2 | 60.96 Million USD | 1.38% |
| 2019 Q4 | 59.34 Million USD | 1.65% |
| 2019 FY | 59.34 Million USD | 139.4% |
| 2019 Q1 | 56.44 Million USD | 127.69% |
| 2019 Q2 | 59.31 Million USD | 5.09% |
| 2019 Q3 | 58.37 Million USD | -1.58% |
| 2018 Q4 | 24.78 Million USD | 74.97% |
| 2018 FY | 24.78 Million USD | 37.59% |
| 2018 Q1 | 17.08 Million USD | -5.17% |
| 2018 Q2 | 15.63 Million USD | -8.52% |
| 2018 Q3 | 14.16 Million USD | -9.36% |
| 2017 Q4 | 18.01 Million USD | 0.55% |
| 2017 Q1 | 17.71 Million USD | 13.26% |
| 2017 FY | 18.01 Million USD | 15.17% |
| 2017 Q2 | 17.81 Million USD | 0.56% |
| 2017 Q3 | 17.91 Million USD | 0.56% |
| 2016 Q1 | 15.36 Million USD | 0.61% |
| 2016 FY | 15.64 Million USD | 2.43% |
| 2016 Q4 | 15.64 Million USD | 0.6% |
| 2016 Q3 | 15.55 Million USD | 0.6% |
| 2016 Q2 | 15.45 Million USD | 0.61% |
| 2015 Q3 | 15.13 Million USD | 0.59% |
| 2015 Q2 | 15.04 Million USD | 0.6% |
| 2015 FY | 15.27 Million USD | 2.74% |
| 2015 Q4 | 15.27 Million USD | 0.93% |
| 2015 Q1 | 14.95 Million USD | 0.6% |
| 2014 Q2 | 14.67 Million USD | 632.85% |
| 2014 Q3 | 14.77 Million USD | 0.66% |
| 2014 Q1 | 2 Million USD | -18.48% |
| 2014 FY | 14.86 Million USD | 505.01% |
| 2014 Q4 | 14.86 Million USD | 0.6% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | 2.45 Million USD | -39.56% |
| 2013 Q4 | 2.45 Million USD | 0.0% |
| 2012 FY | 4.06 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -58624.648% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -988.999% |
| XOMA Corporation | 124.45 Million USD | 32.994% |
| Mesoblast Limited | 118.92 Million USD | 29.88% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 63.616% |
| Aptorum Group Limited | 3.36 Million USD | -2380.046% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -6318.409% |
| HilleVax, Inc. | 51.19 Million USD | -62.891% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -232.997% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -299.292% |
| Precision BioSciences, Inc. | 31.26 Million USD | -166.691% |
| Dyadic International, Inc. | 136.92 Thousand USD | -60799.444% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -52677.848% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -2803.517% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -1428.671% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -38866.822% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -1424.758% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 63.654% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -571.193% |
| IGM Biosciences, Inc. | 40.5 Million USD | -105.868% |
| Opthea Limited | 200.62 Million USD | 58.436% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -61.06% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -1444.241% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -749.781% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -1252.62% |
| NextCure, Inc. | 6.6 Million USD | -1162.513% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -13306.527% |
| Ovid Therapeutics Inc. | 46 Million USD | -81.274% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -292.622% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -175.976% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -34.336% |
| Senti Biosciences, Inc. | 37.66 Million USD | -121.391% |
| Apollomics, Inc. | 4.66 Million USD | -1689.08% |
| PureTech Health plc | 25.51 Million USD | -226.862% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -26122.956% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -542.64% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | 1.518% |
| ChromaDex Corporation | 3.27 Million USD | -2444.675% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | 19.958% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -118.846% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | 20.411% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | 19.459% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | 17.749% |
| Fortress Biotech, Inc. | 88.59 Million USD | 5.873% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -32.014% |
| Celcuity Inc. | 37.44 Million USD | -122.69% |
| ContextLogic Inc. | 6 Million USD | -1289.817% |
| GH Research PLC | 343 Thousand USD | -24211.662% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1171.368% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -225275.676% |
| ImmuCell Corporation | 11.96 Million USD | -596.691% |
| Amarin Corporation plc | 8.73 Million USD | -854.435% |
| TG Therapeutics, Inc. | 110.79 Million USD | 24.736% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -43.081% |
| Acelyrin, Inc. | 1.19 Million USD | -6884.003% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -195.088% |
| Novavax, Inc. | 280.63 Million USD | 70.286% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 40.021% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 98.561% |
| AnaptysBio, Inc. | 17.81 Million USD | -368.109% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -1445.099% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -527.646% |
| AbCellera Biologics Inc. | 77.38 Million USD | -7.766% |
| CorMedix Inc. | 667.63 Thousand USD | -12390.264% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -661.196% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 96.915% |
| Aptose Biosciences Inc. | 1 Million USD | -8157.923% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -963266.451% |
| Soligenix, Inc. | 3.49 Million USD | -2286.251% |
| Century Therapeutics, Inc. | 48.17 Million USD | -73.11% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | 27.595% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -18407.405% |
| Kura Oncology, Inc. | 17.2 Million USD | -384.82% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1107.486% |
| Ardelyx, Inc. | 55.98 Million USD | -48.957% |
| Ainos, Inc. | 5.96 Million USD | -1298.31% |
| TScan Therapeutics, Inc. | 92.43 Million USD | 9.784% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -3778.558% |
| Prothena Corporation plc | 11.83 Million USD | -604.597% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -496.744% |
| Autolus Therapeutics plc | 52.96 Million USD | -57.436% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -230.45% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -99.29% |
| Celularity Inc. | 65.41 Million USD | -27.473% |
| Rallybio Corporation | 392 Thousand USD | -21172.704% |
| GRI Bio, Inc. | 14 Thousand USD | -595535.714% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 75.349% |
| INmune Bio, Inc. | 10.43 Million USD | -698.975% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 53.577% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1311.684% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -101992.311% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -9985.216% |
| Humacyte, Inc. | 58.1 Million USD | -43.512% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -44.092% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 82.658% |
| Immunocore Holdings plc | 84.03 Million USD | 0.765% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -4400.216% |
| Verastem, Inc. | 41.55 Million USD | -100.662% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -633.284% |
| Histogen Inc. | 4.62 Million USD | -1704.176% |
| Surrozen, Inc. | 3.37 Million USD | -2367.86% |
| Blueprint Medicines Corporation | 774.12 Million USD | 89.228% |
| Organovo Holdings, Inc. | 1.39 Million USD | -5881.994% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -3243.585% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -143674.138% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | 1.417% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -39795.225% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -1561.798% |
| Summit Therapeutics Inc. | 106.09 Million USD | 21.405% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | 24.438% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -51274.163% |
| Turnstone Biologics Corp. | 3.21 Million USD | -2494.555% |
| Pulmatrix, Inc. | 8.75 Million USD | -852.364% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -33660.729% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | 14.567% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -502.087% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | 27.705% |
| Cytokinetics, Incorporated | 755.77 Million USD | 88.966% |
| Exelixis, Inc. | 189.94 Million USD | 56.098% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -172.388% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | 24.826% |
| Evogene Ltd. | 1.13 Million USD | -7227.68% |
| Replimune Group, Inc. | 75.86 Million USD | -9.912% |
| PDS Biotechnology Corporation | 23.85 Million USD | -249.616% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -151062.875% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -2893.144% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -103710.626% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -170534.336% |
| BioLineRx Ltd. | 11.59 Million USD | -619.429% |
| Avid Bioservices, Inc. | 207.83 Million USD | 59.877% |
| Insmed Incorporated | 1.2 Billion USD | 93.074% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -3833.443% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -82.179% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -128190.769% |
| MediWound Ltd. | 6.71 Million USD | -1142.572% |
| MiMedx Group, Inc. | 48.09 Million USD | -73.37% |
| OmniAb, Inc. | 25.56 Million USD | -226.235% |
| Alector, Inc. | 38.91 Million USD | -114.268% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 61.022% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 79.908% |
| Mereo BioPharma Group plc | 5.95 Million USD | -1301.025% |
| Zai Lab Limited | 15.15 Million USD | -450.386% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 82.57% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -5000.245% |
| Aura Biosciences, Inc. | 19.55 Million USD | -326.39% |
| Immunic, Inc. | 1.33 Million USD | -6151.049% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -204.173% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -162.792% |
| Veracyte, Inc. | 12.63 Million USD | -560.245% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 87.069% |
| FibroGen, Inc. | 170.45 Million USD | 51.079% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -818.28% |
| Allakos Inc. | 41.46 Million USD | -101.107% |
| scPharmaceuticals Inc. | 40.26 Million USD | -107.08% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -670.622% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -55124.503% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -5004.159% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -40794.802% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -1868.114% |
| Precigen, Inc. | 7.09 Million USD | -1074.989% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 95.03% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1039.661% |
| Incyte Corporation | 38.28 Million USD | -117.8% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -27630.335% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -93.178% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -648.689% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -2893.144% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 65.055% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -220.197% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -23793.696% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -210.215% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -85.009% |
| Agenus Inc. | 350.24 Million USD | 76.191% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -77913.116% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -5776.603% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -84.342% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -93.169% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -72.902% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -50757.185% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 90.175% |
| UroGen Pharma Ltd. | 100.21 Million USD | 16.789% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -8016.523% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 54.37% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -587394.716% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -27240.656% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -21172.596% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1120.029% |
| Chimerix, Inc. | 2.14 Million USD | -3789.412% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -8470.298% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -134.533% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -48193.016% |
| Pluri Inc. | 29.61 Million USD | -181.605% |
| Cue Biopharma, Inc. | 14.69 Million USD | -467.465% |
| MeiraGTx Holdings plc | 89.26 Million USD | 6.582% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -390480.796% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -1609.842% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -34.894% |
| Sana Biotechnology, Inc. | 104.09 Million USD | 19.892% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1105.566% |
| NLS Pharmaceutics AG | 1.63 Million USD | -5004.159% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -164.324% |
| Nutriband Inc. | 241.28 Thousand USD | -34460.375% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -1425.316% |
| Vor Biopharma Inc. | 35.66 Million USD | -133.845% |
| Roivant Sciences Ltd. | 499.74 Million USD | 83.314% |
| ProKidney Corp. | 4.41 Million USD | -1789.622% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -6701.713% |
| Daré Bioscience, Inc. | 5.31 Million USD | -1468.009% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 95.207% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -14659.115% |
| Bicycle Therapeutics plc | 44.95 Million USD | -85.49% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -114.257% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -16.129% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | 5.179% |
| Atai Life Sciences N.V. | 16.47 Million USD | -406.124% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -3302.25% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -12253.926% |
| MediciNova, Inc. | 215.92 Thousand USD | -38519.249% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -3242.244% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -6512.779% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -7208.414% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 55.257% |
| Biomea Fusion, Inc. | 10.29 Million USD | -709.916% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -49.285% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -2222.813% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -810.261% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -468.393% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -580.282% |
| bluebird bio, Inc. | 330.32 Million USD | 74.756% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -566.792% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -5032.534% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 92.646% |
| BioAtla, Inc. | 2.46 Million USD | -3289.797% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | 12.334% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -1403.588% |
| DBV Technologies S.A. | 14.38 Million USD | -479.855% |
| Fortress Biotech, Inc. | 88.59 Million USD | 5.873% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -746.417% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -340.443% |
| aTyr Pharma, Inc. | 15.09 Million USD | -452.428% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -296.185% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -25440.823% |
| Galecto, Inc. | 249 Thousand USD | -33389.558% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -5010.481% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 94.438% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | 21.379% |
| Entera Bio Ltd. | 390 Thousand USD | -21281.795% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 79.399% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -1243.251% |
| Xencor, Inc. | 83.43 Million USD | 0.054% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -4843.035% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -1709.264% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -6711.569% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -786.74% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -50757.185% |
| Portage Biotech Inc. | 47 Thousand USD | -177323.404% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -6512.779% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -3350.103% |
| OncoCyte Corporation | 2.86 Million USD | -2806.553% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -55288.1% |
| Purple Biotech Ltd. | 351 Thousand USD | -23657.55% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -2539.728% |
| Onconetix, Inc. | 9.88 Million USD | -743.525% |
| MacroGenics, Inc. | 33.97 Million USD | -145.471% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -3999.756% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -1494.131% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -511.67% |
| Aditxt, Inc. | 18.21 Million USD | -357.729% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -211.874% |
| Curis, Inc. | 2.79 Million USD | -2884.574% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -3803.159% |
| Adagene Inc. | 22.3 Million USD | -273.827% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -398.41% |
| BeiGene, Ltd. | 930.18 Million USD | 91.035% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 60.318% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -10215.289% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 86.351% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -109622.368% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -3232.894% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1.673% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 59.503% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -1695.629% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 96.892% |
| ADMA Biologics, Inc. | 141.41 Million USD | 41.034% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -37.653% |
| Clene Inc. | 32.16 Million USD | -159.286% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -3180.448% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -342.312% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -3699.043% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -64.566% |
| Adicet Bio, Inc. | 20.92 Million USD | -298.533% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 56.836% |
| Absci Corporation | 15.95 Million USD | -422.586% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -444.919% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -310.925% |
| Surrozen, Inc. | 3.37 Million USD | -2367.86% |
| Generation Bio Co. | 97.89 Million USD | 14.817% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -25246.201% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -203.398% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -229.627% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -239.781% |
| Invivyd, Inc. | 2.16 Million USD | -3751.686% |
| Cingulate Inc. | 3.13 Million USD | -2559.852% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -55.966% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -2366398.001% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -16547.734% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -1404.402% |
| Jaguar Health, Inc. | 35.86 Million USD | -132.54% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -132263.492% |
| 2seventy bio, Inc. | 256.67 Million USD | 67.512% |
| Clearside Biomedical, Inc. | 43 Million USD | -93.923% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -13729.022% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -45.772% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -1385.864% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -17227.764% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -194.953% |
| Innoviva, Inc. | 449.07 Million USD | 81.431% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -312.429% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -22.217% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -384.904% |
| Vir Biotechnology, Inc. | 124.54 Million USD | 33.042% |
| Evaxion Biotech A/S | 10.86 Million USD | -667.171% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -11.323% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1183.698% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -203287.805% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -208.963% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -17833.118% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -204.018% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -716.499% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -2244.363% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -5262.637% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -6518.175% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -477.326% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -9104.084% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -61.207% |
| ImmunityBio, Inc. | 883.67 Million USD | 90.563% |
| Korro Bio, Inc. | 33.2 Million USD | -151.119% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -17.489% |
| Kineta, Inc. | 1.31 Million USD | -6231.739% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -35464.739% |
| BioVie Inc. | 6.11 Million USD | -1264.472% |
| Codexis, Inc. | 22.36 Million USD | -272.872% |
| Celularity Inc. | 65.41 Million USD | -27.473% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -21672.585% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -37077.441% |
| Kodiak Sciences Inc. | 181.63 Million USD | 54.089% |
| Cibus, Inc. | 24.62 Million USD | -238.691% |
| Annexon, Inc. | 31.35 Million USD | -165.951% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -3460.589% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 94.263% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -11.132% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -2036.536% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -417.695% |
| Puma Biotechnology, Inc. | 111.49 Million USD | 25.205% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -81.127% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -159.633% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -8365.888% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -627.843% |
| Alkermes plc | 290.73 Million USD | 71.317% |
| Arcellx, Inc. | 97.62 Million USD | 14.582% |
| Moolec Science SA | 2.64 Million USD | -3052.359% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -3780.363% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -1220.909% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -214.521% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -2588.233% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -3371.649% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -4711.829% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -43.512% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -192.727% |
| Geron Corporation | 85.89 Million USD | 2.922% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -83.232% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 98.641% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -72252.37% |
| Notable Labs, Ltd. | 2.04 Million USD | -3969.741% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -146.494% |
| Structure Therapeutics Inc. | 5.45 Million USD | -1429.231% |
| IN8bio, Inc. | 4.89 Million USD | -1604.251% |
| 89bio, Inc. | 27.1 Million USD | -207.618% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -20747.25% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -55.264% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -3210.401% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -6132.362% |
| Liquidia Corporation | 3.5 Million USD | -2280.502% |
| Mustang Bio, Inc. | 2.49 Million USD | -3238.231% |
| Immunovant, Inc. | 138 Thousand USD | -60326.812% |
| Vericel Corporation | 88.14 Million USD | 5.394% |
| Quantum-Si incorporated | 15.3 Million USD | -444.919% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -856.186% |
| XOMA Corporation | 124.45 Million USD | 32.994% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -30333.942% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -101992.311% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -528.118% |
| Vaxcyte, Inc. | 29.22 Million USD | -185.344% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -664.826% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -40978.325% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -303.606% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -4944.707% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -6518.175% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -20592.06% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -7980.329% |
| PepGen Inc. | 20.1 Million USD | -314.788% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -14427.7% |
| United Therapeutics Corporation | 700 Million USD | 88.087% |
| Solid Biosciences Inc. | 26.26 Million USD | -217.491% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -8365.888% |
| Immuneering Corporation | 4.46 Million USD | -1768.469% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -82463.366% |
| Belite Bio, Inc | 886 Thousand USD | -9311.851% |
| Pharming Group N.V. | 171.54 Million USD | 51.389% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 65.199% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -290.929% |
| uniQure N.V. | 138.4 Million USD | 39.752% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -395.478% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | 2.381% |
| Altimmune, Inc. | 671 Thousand USD | -12327.571% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -528.118% |
| Peak Bio, Inc. | 10.72 Million USD | -677.751% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -818.28% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -4673.268% |
| Benitec Biopharma Inc. | 284 Thousand USD | -29262.324% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 81.263% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -28690.269% |
| Compugen Ltd. | 1.35 Million USD | -6072.391% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -39516.797% |
| argenx SE | 20 Million USD | -316.945% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -94.989% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | 1.379% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -318.598% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | 28.845% |
| PolyPid Ltd. | 11.77 Million USD | -607.946% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | 8.823% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -1894.475% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -14154.53% |
| Instil Bio, Inc. | 86.05 Million USD | 3.097% |
| Elevation Oncology, Inc. | 30.13 Million USD | -176.7% |
| Immunome, Inc. | 1.65 Million USD | -4953.879% |
| Verona Pharma plc | 51.32 Million USD | -62.46% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -752.823% |
| Shattuck Labs, Inc. | 4.2 Million USD | -1884.507% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -22935.635% |
| Design Therapeutics, Inc. | 3.05 Million USD | -2634.066% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -31727.863% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -486.091% |
| Achilles Therapeutics plc | 4.61 Million USD | -1706.912% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 77.687% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -177.049% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -2155.057% |
| Beam Therapeutics Inc. | 173.17 Million USD | 51.846% |
| Moolec Science SA | 2.64 Million USD | -3052.359% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -17455.579% |
| AEON Biopharma, Inc. | 278 Thousand USD | -29896.043% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1087.201% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -24792.239% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -9.922% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -36.464% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -176.038% |
| Athira Pharma, Inc. | 1.58 Million USD | -5161.136% |
| HCW Biologics Inc. | 6.45 Million USD | -1192.497% |
| XOMA Corporation | 124.45 Million USD | 32.994% |
| NeurAxis, Inc. | 224.26 Thousand USD | -37084.072% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1166.348% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -752.823% |
| 180 Life Sciences Corp. | 1.32 Million USD | -6217.018% |
| Nektar Therapeutics | 230.4 Million USD | 63.807% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -318.598% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -388.223% |
| Arvinas, Inc. | 3.4 Million USD | -2352.618% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -5262.637% |
| Palisade Bio, Inc. | 369 Thousand USD | -22498.645% |
| Nutriband Inc. | 241.28 Thousand USD | -34460.375% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -5010.481% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -9995.521% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -19993.735% |
| Merus N.V. | 12.16 Million USD | -585.652% |
| Omega Therapeutics, Inc. | 128.42 Million USD | 35.069% |
| Neurogene Inc. | 16.25 Million USD | -413.005% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 72.938% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -192.173% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -503.656% |
| Rezolute, Inc. | 2.22 Million USD | -3642.774% |
| Clene Inc. | 32.16 Million USD | -159.286% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -47536.43% |
| BeyondSpring Inc. | 3.99 Million USD | -1987.334% |
| Synlogic, Inc. | 17.27 Million USD | -382.715% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -6314.538% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -238154.286% |
| Peak Bio, Inc. | 10.72 Million USD | -677.751% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -60.601% |
| Krystal Biotech, Inc. | 8.09 Million USD | -930.257% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 52.892% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1081.649% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -60948.802% |
| MannKind Corporation | 382.37 Million USD | 78.192% |
| Ikena Oncology, Inc. | 10.73 Million USD | -676.579% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -20288.509% |
| Gossamer Bio, Inc. | 212.46 Million USD | 60.751% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -47824.713% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -810.261% |
| Legend Biotech Corporation | 328.67 Million USD | 74.629% |
| Mural Oncology plc | 15 Million USD | -455.593% |
| Disc Medicine, Inc. | 2.1 Million USD | -3869.015% |
| Champions Oncology, Inc. | 7.43 Million USD | -1022.328% |
| REGENXBIO Inc. | 89.29 Million USD | 6.609% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -9656.557% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -14979.876% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -1440.248% |
| Vaxart, Inc. | 26.51 Million USD | -214.509% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -432.587% |
| Cellectis S.A. | 92.85 Million USD | 10.192% |
| Longeveron Inc. | 2.04 Million USD | -3985.693% |
| Repare Therapeutics Inc. | 3.41 Million USD | -2345.425% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 94.03% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -78.977% |
| Revolution Medicines, Inc. | 87.94 Million USD | 5.179% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -48101.734% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -2009.512% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -26205.678% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -47550.857% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 89.685% |
| Denali Therapeutics Inc. | 52.24 Million USD | -59.624% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -478.871% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -5969.068% |
| Cingulate Inc. | 3.13 Million USD | -2559.852% |
| Passage Bio, Inc. | 26.29 Million USD | -217.141% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1151.148% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -20338.48% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -9227.629% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -305.569% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -3302.076% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -2570.157% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -10182.244% |
| OmniAb, Inc. | 25.56 Million USD | -226.235% |
| Anew Medical, Inc. | 1.6 Million USD | -5095.576% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -181.883% |
| Lipocine Inc. | 17.16 Thousand USD | -485680.03% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -616.523% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -140.814% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -1311.684% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -45.854% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -40978.325% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -1514.501% |
| Ocugen, Inc. | 6.94 Million USD | -1101.397% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -490.197% |
| Q32 Bio Inc. | 1.31 Million USD | -6226.935% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -12309.077% |
| Alumis Inc. Common Stock | 32.58 Million USD | -155.952% |
| Equillium, Inc. | 824 Thousand USD | -10020.024% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -818.482% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -27621.854% |
| Dominari Holdings Inc. | 3.02 Million USD | -2653.93% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -88154.469% |
| vTv Therapeutics Inc. | 529 Thousand USD | -15663.516% |
| Bio-Techne Corporation | 419.53 Million USD | 80.124% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -15.824% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 56.92% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -393.777% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -266.352% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -1276.51% |
| Nkarta, Inc. | 88.33 Million USD | 5.603% |
| BioCardia, Inc. | 1.31 Million USD | -6241.369% |
| Iterum Therapeutics plc | 19.5 Million USD | -327.439% |